Neurology Medical News about Valproic Acid

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Doctors and the DEA Free full text

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Valproic acid-induced encephalopathy in very long course treated patients
Brain Injury, 10/22/09

Rousseau MC et al. – This study confirms that, under VPA treatment, hyperammonaemia is a current event; 25.4% patients presented isolated elevated ammonaemia when receiving VPA for very long durations. VPA therapy should be monitored closely and clinicians must be warned of VPA encephalopathy signs.

<< Previous
Disruptive behaviour disorders and disruptive symptoms after...

Next >>
Active rehabilitation for children who are slow to recover...

Molecular and Clinical Assessment in the Treatment of AIDS Kaposi Sarcoma with Valproic Acid
Clinical Infectious Diseases, 11/16/09 Relevance Score: 66%

Direct hepatic differentiation of embryonic stem cells induced by valproic acid and cytokines
World Journal of Gastroenterology, 11/12/09 Relevance Score: 64%

Risk factors for valproic acid resistance in childhood absence epilepsy
Seizure - European Journal of Epilepsy, 10/21/09 Relevance Score: 64%

Multiple organ dysfunction syndrome: infection or hypersensitivity reaction
European Journal of Emergency Medicine, 10/12/09 Relevance Score: 64%

Peroxisome proliferator-activated receptor gamma agonists potentiate the cytotoxic effect of valproic acid in multiple myeloma cells
British Journal of Haematology, 10/08/09 Relevance Score: 64%